Newmont Corporation vs Tilray Brands Inc — how do they compare? Newmont Corporation trades at $92.48 (market cap $95.23B), while Tilray Brands Inc trades at $4.24 (market cap $524.07M). The key difference: Newmont Corporation is far larger — about 181.7× Tilray Brands Inc's market cap, and Newmont Corporation pays a 1.17% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| NEM | TLRY | |
|---|---|---|
Market Cap | $95.23B | $524.07M |
Sector | Basic Materials | Health |
52-Week High | $131.95 | $21.00 |
52-Week Low | $59.86 | $4.23 |
Enterprise Value | $91.98B | $621.22M |
Dividend Yield | 1.17% | — |
Signals from Pluang's Aura AI — not financial advice
Newmont (NEM) trades at $92.49, up 3.11% today, with a bearish technical signal but strong fundamentals. The stock has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected soon. Revenue grew to $22.67B in 2025, net income surged to $7.09B, and cash flow from operations hit $10.33B. Analyst consensus is strongly bullish with a $134.63 price target, though technical indicators show selling pressure near resistance at $92.
The outlook is positive given robust profitability, low P/E of 11.57, and gold price tailwinds, but risks include rising unit costs and production volatility. With 76% of analysts rating it Buy and institutional interest steady, NEM offers value if operational execution holds.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →